Cited In for PMID: 21603867

Year	Number of Results
2011	2
2012	4
2013	4
2014	3
2015	9
2016	7
2017	8
2018	8
2019	12
2020	11
2021	9
2022	8
2023	9
2024	2

1

Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers.

Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T. Kanai M, et al. Cancer Chemother Pharmacol. 2012 Jan;69(1):65-70. doi: 10.1007/s00280-011-1673-1. Epub 2011 May 21. Cancer Chemother Pharmacol. 2012. PMID: 21603867 Free article. Clinical Trial.

2

Longevity and anti-aging effects of curcumin supplementation.

Izadi M, Sadri N, Abdi A, Zadeh MMR, Jalaei D, Ghazimoradi MM, Shouri S, Tahmasebi S. Izadi M, et al. Geroscience. 2024 Jun;46(3):2933-2950. doi: 10.1007/s11357-024-01092-5. Epub 2024 Feb 27. Geroscience. 2024. PMID: 38409646 Free PMC article. Review.

3

Green Cancer Prevention and Beyond.

Ross SA, Emenaker NJ, Kumar A, Riscuta G, Biswas K, Gupta S, Mohammed A, Shoemaker RH. Ross SA, et al. Cancer Prev Res (Phila). 2024 Mar 4;17(3):107-118. doi: 10.1158/1940-6207.CAPR-23-0308. Cancer Prev Res (Phila). 2024. PMID: 38251904 Free PMC article. Review.

4

Non-therapeutic plasma levels in individuals utilizing curcumin supplements in daily life.

Kroon MAGM, Berbee JK, Majait S, Swart EL, van Tellingen O, van Laarhoven HWM, Kemper EM. Kroon MAGM, et al. Front Nutr. 2023 Nov 30;10:1267035. doi: 10.3389/fnut.2023.1267035. eCollection 2023. Front Nutr. 2023. PMID: 38099182 Free PMC article.

5

Recent Strategies for Cancer Therapy: Polymer Nanoparticles Carrying Medicinally Important Phytochemicals and Their Cellular Targets.

Yıldırım M, Sessevmez M, Poyraz S, Düzgüneş N. Yıldırım M, et al. Pharmaceutics. 2023 Nov 1;15(11):2566. doi: 10.3390/pharmaceutics15112566. Pharmaceutics. 2023. PMID: 38004545 Free PMC article. Review.

6

Potential of Dietary HDAC2i in Breast Cancer Patients Receiving PD-1/PD-L1 Inhibitors.

Wang Y, Lu L, Ling C, Zhang P, Han R. Wang Y, et al. Nutrients. 2023 Sep 14;15(18):3984. doi: 10.3390/nu15183984. Nutrients. 2023. PMID: 37764768 Free PMC article. Review.

7

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces.

Kroon MAGM, van Laarhoven HWM, Swart EL, Kemper EM, van Tellingen O. Kroon MAGM, et al. Heliyon. 2023 Apr 20;9(5):e15540. doi: 10.1016/j.heliyon.2023.e15540. eCollection 2023 May. Heliyon. 2023. PMID: 37131436 Free PMC article.

8

Exploring the Contribution of Curcumin to Cancer Therapy: A Systematic Review of Randomized Controlled Trials.

de Waure C, Bertola C, Baccarini G, Chiavarini M, Mancuso C. de Waure C, et al. Pharmaceutics. 2023 Apr 19;15(4):1275. doi: 10.3390/pharmaceutics15041275. Pharmaceutics. 2023. PMID: 37111761 Free PMC article. Review.

9

Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.

Kunnumakkara AB, Hegde M, Parama D, Girisa S, Kumar A, Daimary UD, Garodia P, Yenisetti SC, Oommen OV, Aggarwal BB. Kunnumakkara AB, et al. ACS Pharmacol Transl Sci. 2023 Mar 6;6(4):447-518. doi: 10.1021/acsptsci.2c00012. eCollection 2023 Apr 14. ACS Pharmacol Transl Sci. 2023. PMID: 37082752 Free PMC article. Review.

10

Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?

Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Hegde M, et al. ACS Omega. 2023 Mar 13;8(12):10713-10746. doi: 10.1021/acsomega.2c07326. eCollection 2023 Mar 28. ACS Omega. 2023. PMID: 37008131 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

87 results

Results by year